Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 141,866 | 439,999 | 81,879 |
| Receivables | 129,202 | 86,928 | 43,038 |
| Inventories | 37,080 | 23,620 | 11,501 |
| Other current assets | 22,132 | 19,570 | 18,058 |
| TOTAL | $330,280 | $570,117 | $154,476 |
| Non-Current Assets | |||
| PPE Net | 58,661 | 27,841 | 15,394 |
| Intangibles | 592,823 | 257,858 | 72,860 |
| Other Non-Current Assets | 182,222 | 84,563 | 26,989 |
| TOTAL | $833,706 | $370,262 | $115,243 |
| Total Assets | $1,163,986 | $940,379 | $269,719 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 13,110 | 11,763 | 641 |
| Accounts payable and accrued liabilities | 150,349 | 86,790 | 54,284 |
| Other current liabilities | 31,875 | 74,902 | 41,616 |
| TOTAL | $231,624 | $205,088 | $109,669 |
| Non-Current Liabilities | |||
| Long Term Debt | 391,914 | 341,811 | 5,454 |
| Other Non-Current Liabilities | 23,832 | 29,705 | 50,559 |
| TOTAL | $516,986 | $382,354 | $61,114 |
| Total Liabilities | $748,610 | $587,442 | $170,782 |
| Shareholders' Equity | |||
| Common Shares | 479,962 | 414,012 | 296,501 |
| Retained earnings | -154,538 | -152,914 | -175,179 |
| Other shareholders' equity | 101,564 | 75,894 | 19,359 |
| TOTAL | $415,376 | $352,937 | $98,937 |
| Total Liabilities And Equity | $1,163,986 | $940,379 | $269,719 |